---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-24-000039"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2024-03-26T23:59:59+00:00"
generated_at: "2026-06-04T07:32:09.773702+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# EY declines reappointment as Lifecore auditor; cites material weaknesses in internal controls

## Summary
- Ernst & Young notified Lifecore on March 20, 2024 it will not stand for reappointment as auditor for FY ending May 26, 2024.
- EY issued adverse opinions on internal controls for FY2023 and FY2022 due to material weaknesses.
- EY's FY2022 audit report included a going-concern explanatory paragraph.
- No accounting disagreements; company is actively seeking a new independent registered public accounting firm.

## SEC filing metadata
- accession: 0001005286-24-000039
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2024-03-26T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000039/0001005286-24-000039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000039/lndc-20240320.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-24-000039
- JSON: https://secwatch.observer/filing/0001005286-24-000039.json
- Plain text: https://secwatch.observer/filing/0001005286-24-000039.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.